Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
198
TGA:198
Drug Approvals
BENDAMUSTINE HYDROCHLORIDE MEDICIANZ bendamustine hydrochloride (as monohydrate) 25 mg powder for injection vial (427130)
- Product Name
- BENDAMUSTINE HYDROCHLORIDE MEDICIANZ bendamustine hydrochloride (as monohydrate) 25 mg powder for injection vial
- Approval Date
- Jul 10, 2025
TGA
BENDAMUSTINE HYDROCHLORIDE MEDICIANZ bendamustine hydrochloride (as monohydrate) 100 mg powder for injection vial (427132)
- Product Name
- BENDAMUSTINE HYDROCHLORIDE MEDICIANZ bendamustine hydrochloride (as monohydrate) 100 mg powder for injection vial
- Approval Date
- Jul 10, 2025
TGA
BENDAMUSTINE HYDROCHLORIDE MEDSURGE bendamustine hydrochloride (as monohydrate) 25 mg powder for injection vial (427131)
- Product Name
- BENDAMUSTINE HYDROCHLORIDE MEDSURGE bendamustine hydrochloride (as monohydrate) 25 mg powder for injection vial
- Approval Date
- Jul 10, 2025
TGA
BENDAMUSTINE HYDROCHLORIDE MEDSURGE bendamustine hydrochloride (as monohydrate) 100 mg powder for injection vial (427133)
- Product Name
- BENDAMUSTINE HYDROCHLORIDE MEDSURGE bendamustine hydrochloride (as monohydrate) 100 mg powder for injection vial
- Approval Date
- Jul 10, 2025
TGA
BIVALIRUDIN MEDSURGE bivalirudin (as trifluoroacetate) 250 mg powder for injection vial (427182)
- Product Name
- BIVALIRUDIN MEDSURGE bivalirudin (as trifluoroacetate) 250 mg powder for injection vial
- Approval Date
- Jul 9, 2025
TGA
BIVALIRUDIN MEDICIANZ bivalirudin (as trifluoroacetate) 250 mg powder for injection vial (427181)
- Product Name
- BIVALIRUDIN MEDICIANZ bivalirudin (as trifluoroacetate) 250 mg powder for injection vial
- Approval Date
- Jul 9, 2025
TGA
EPTIFIBATIDE MEDICIANZ eptifibatide (as acetate) 75 mg/100 mL solution for injection vial (431134)
- Product Name
- EPTIFIBATIDE MEDICIANZ eptifibatide (as acetate) 75 mg/100 mL solution for injection vial
- Approval Date
- Jun 20, 2025
TGA
EPTIFIBATIDE MEDSURGE eptifibatide (as acetate) 75 mg/100 mL solution for injection vial (431136)
- Product Name
- EPTIFIBATIDE MEDSURGE eptifibatide (as acetate) 75 mg/100 mL solution for injection vial
- Approval Date
- Jun 20, 2025
TGA
EPTIFIBATIDE MEDSURGE eptifibatide (as acetate) 20 mg/10 mL solution for injection vial (431135)
- Product Name
- EPTIFIBATIDE MEDSURGE eptifibatide (as acetate) 20 mg/10 mL solution for injection vial
- Approval Date
- Jun 20, 2025
TGA
EPTIFIBATIDE MEDICIANZ eptifibatide (as acetate) 20 mg/10 mL solution for injection vial (431133)
- Product Name
- EPTIFIBATIDE MEDICIANZ eptifibatide (as acetate) 20 mg/10 mL solution for injection vial
- Approval Date
- Jun 20, 2025
TGA
- Prev
- 1
- 2
- 3
- 4
- 5
- 20
- Next
Clinical Trials
No trials found
News
No news found